| 2019 novel coronavirus (COVID-19) outbreak: a review of the current literature AR Sahin, A Erdogan, PM Agaoglu, Y Dineri, AY Cakirci, ME Senel, ... EJMO 4 (1), 1-7, 2020 | 384 | 2020 |
| Corona virus: a review of COVID-19 D Kumar, R Malviya, PK Sharma EJMO 4 (1), 8-25, 2020 | 126 | 2020 |
| A review of COVID-19 (Coronavirus Disease-2019) diagnosis, treatments and prevention A Hafeez, S Ahmad, SA Siddqui, M Ahmad, S Mishra EJMO 4 (2), 116-125, 2020 | 98* | 2020 |
| Modeling and Forecasting for the number of cases of the COVID-19 pandemic with the Curve Estimation Models, the Box-Jenkins and Exponential Smoothing Methods H Yonar, A Yonar, MA Tekindal, M Tekindal EJMO 4 (2), 160-165, 2020 | 44 | 2020 |
| The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2 RR Narkhede, RS Cheke, JP Ambhore, SD Shinde Eurasian J. Med. Oncol 4 (3), 185-195, 2020 | 42 | 2020 |
| Cytokine-targeted therapy in severely ill COVID-19 patients: options and cautions M Rahmati, MA Moosavi mortality, 105954, 2020 | 28 | 2020 |
| Frequency of RAS mutations (KRAS, NRAS, HRAS) in human solid cancer H Kodaz, O Kostek, MB Hacioglu, B Erdogan, CE Kodaz, I Hacibekiroglu, ... Breast cancer 7 (5), 2017 | 26 | 2017 |
| Case fatality rate estimation of COVID-19 for European countries: Turkey’s current scenario amidst a global pandemic; comparison of outbreaks with European countries F Öztoprak, A Javed ejmo 21, 24, 2020 | 25 | 2020 |
| Genome organization of Covid-19 and emerging severe acute respiratory syndrome Covid-19 outbreak: A pandemic HS Dagur, SS Dhakar EJMO 4 (2), 107-115, 2020 | 18 | 2020 |
| IN silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors H Hashem Eurasian J. Med. Oncol 4, 196-200, 2020 | 17 | 2020 |
| Why are Children Less Affected by COVID-19 ? Could there be an Overlooked Bacterial Co-Infection? MT Ramazan Azim Okyay, Ahmet Rıza Sahin, Rene A. Aguinada Eurasian Journal of Medicine and Oncology 4 (1), 104-105, 2020 | 14* | 2020 |
| Successful Treatment Strategy of Turkey against Covid-19 Outbreak H Kodaz EJMO 4 (2), 177, 2020 | 10 | 2020 |
| The Impacts of Covariates on Spatial Distribution of Corona Virus 2019 (COVID-19): What Do the Data Show through ANCOVA and MANCOVA? HT Likassa Eurasian Journal of Medicine and Oncology 4 (2), 141-148, 2020 | 10 | 2020 |
| The rise of new coronavirus infection (COVID-19): A recent update and potential therapeutic candidates SN Mali, AP Pratapb, BR Thorat EJMO 4 (1), 35-41, 2020 | 9 | 2020 |
| The rise of new coronavirus infection (COVID-19): A recent update and potential therapeutic candidates SN Mali, AP Pratapb, BR Thorat EJMO 4 (1), 35-41, 2020 | 9 | 2020 |
| Recombinant human angiotensin-converting enzyme 2 and COVID-19 acute respiratory distress syndrome: a theoretical or a real resource M Barone, C Ucciferri, G Cipollone, F Mucilli EJMO 4 (2), 139-140, 2020 | 7 | 2020 |
| Computed Tomography Organ Dose Determination Using ImPACT Simulation Software: Our Findings In South-West Nigeria JCE MO Akpochafor, AD Omojola, MY Habeebu Eurasian journal of medicine and oncology https://www.ejmo.org/10.14744 …, 2018 | 7* | 2018 |
| Vitamin D deficiency and toxicity SM Buyuker EJMO 3, 1-5, 2019 | 6 | 2019 |
| The prevalence of insulin resistance in the Turkish population: a study conducted with 3331 participants A Kaya, E Turan, M Uyar, F Bayram, Y Turan EJMO 1 (4), 202-206, 2017 | 6 | 2017 |
| Enzalutamide in Prostate Cancer, A Review on Enzalutamide and cancer MB Bulent Erdogan, Osman Kostek Eurasian Journal of Medicine and Oncology 2 (3), 121-129, 2018 | 5* | 2018 |
